Table 3.
Parameter* | OR | 95% CI |
---|---|---|
Group (Policy Affected vs. Comparison) | 2.65 | (2.48, 2.84) |
| ||
Months of Opioid Use | 0.74 | (0.73, 0.76) |
| ||
Average Daily Dose (per 100 mg MED) | 0.46 | (0.41, 0.52) |
| ||
Mental Health Diagnosis:† | ||
Dementia | 1.43 | (1.19, 1.73) |
MDD | 1.16 | (1.07, 1.27) |
Schizophrenia | 1.40 | (1.05, 1.86) |
| ||
Substance Use Disorders† | ||
Non Opioid | 1.41 | (1.13, 1.77) |
| ||
Race: | ||
Black | 1.15 | (1.01, 1.30) |
Other | 1.14 | (1.02, 1.27) |
Missing | 1.02 | (0.77, 1.34) |
Referent: Race: White | ||
| ||
Age: | ||
18–25 | 1.64 | (0.51, 5.24) |
26–35 | 1.62 | (1.16, 2.26) |
36–45 | 0.86 | (0.71, 1.05) |
46–55 | 0.97 | (0.85, 1.10) |
66–75 | 1.24 | (1.12, 1.36) |
76+ | 1.51 | (1.38, 1.65) |
Referent: Age: 56–65 |
significant parameters (p<0.05) after stepwise regression
For each diagnosis (mental health, substance use disorder, or pain), the null serves as the referent